University of Nebraska Medical Center (UNMC) - Nebraska Medicine - Nebraska Medical Center

Omaha, Nebraska 68198-3040

1 studies enrolling now · 1 studies all time

What they study most

Antibody-mediated Rejection, Microvascular Inflammation

Studies at this site

• A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE) — Enrolling by invitation